M. W. Tenforde, M. Mokomane, and T. Leeme, Advanced human immunodeficiency virus disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal meningitis, Clin Infect Dis, vol.65, pp.779-786, 2017.

, An article demonstrating that despite widened access to antiretrovial therapy there are similar numbers of cases of cryptococcal meningitis seen now than in the pretreatment era

M. Osler, K. Hilderbrand, and E. Goemaere, The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa, Clin Infect Dis, vol.66, issue.Suppl_2, pp.118-125, 2018.

L. M. Coetzee, N. Cassim, and C. Sriruttan, Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/ml identifies districts in South Africa with advanced burden of disease, PLoS One, vol.13, p.198993, 2018.

A. G. Flynn, D. B. Meya, and K. H. Hullsiek, Evolving failures in the delivery of human immunodeficiency virus care: lessons from a Ugandan Meningitis Cohort, Open Forum Infect Dis, vol.4, p.77, 2017.

E. Mpoza, L. Mukaremera, and D. A. Kundura, Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection, PLoS One, vol.13, p.190652, 2018.

E. Temfack, C. Kouanfack, and L. Mossiang, Cryptococcal antigen screening in asymptomatic HIV-infected antiretroviral naive patients in Cameroon and evaluation of the new semi-quantitative, Biosynex CryptoPS Test. Front Microbiol, vol.9, p.409, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01852122

R. Kwizera, A. Akampurira, and D. Williams, Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients, PLoS One, vol.12, p.182108, 2017.

J. N. Jarvis, T. Bicanic, and A. Loyse, Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes, Clin Infect Dis, vol.58, pp.736-745, 2014.

R. Kwizera, A. Akampurira, and T. K. Kandole, Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid, Med Mycol, vol.56, pp.559-564, 2018.

J. E. Scriven, L. M. Graham, and C. Schutz, Flow cytometry to assess cerebrospinal fluid fungal burden in cryptococcal meningitis, J Clin Microbiol, vol.54, pp.802-804, 2016.

B. J. Mcmullan, D. Desmarini, and J. T. Djordjevic, Rapid microscopy and use of vital dyes: potential to determine viability of cryptococcus neoformans in the clinical laboratory, PLoS One, vol.10, p.117186, 2015.

J. N. Jarvis, S. D. Lawn, and M. Vogt, Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa, Clin Infect Dis, vol.48, pp.856-862, 2009.

&. Who, Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva: World Health Organisation, 2018.

R. M. Wake, E. Britz, and C. Sriruttan, High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among HIV-infected patients, Clin Infect Dis, vol.66, pp.686-692, 2018.

, The study highlights the need for CrAg screening and the importance of identifying, investigating and treating those with a positive test to avoid development of cryptococcal meningitis

E. Temfack, J. J. Bigna, and H. N. Luma, Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral naive HIV-infected adults with less than 100 CD4 cells/mL: a systematic review and meta-analysis, Clin Infect Dis, 2018.

A. Ramachandran, Y. Manabe, R. Rajasingham, and M. Shah, Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda, BMC Infect Dis, vol.17, p.225, 2017.

B. A. Larson, P. C. Rockers, and R. Bonawitz, Screening HIV-infected patients with low CD4 counts for cryptococcal antigenemia prior to initiation of antiretroviral therapy: cost effectiveness of alternative screening strategies in South Africa, PLoS One, vol.11, p.158986, 2016.

S. Vallabhaneni, N. Longley, and M. Smith, Implementation and operational research: evaluation of a public-sector, provider-initiated cryptococcal antigen screening and treatment program, J Acquir Immune Defic Syndr, vol.72, pp.37-42, 2016.

N. P. Govender, M. Roy, and J. F. Mendes, Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa, HIV Med, vol.16, pp.468-476, 2015.

R. M. Wake, D. K. Glencross, and C. Sriruttan, Cryptococcal antigen screening in HIV-infected adults: let's get straight to the point, AIDS, vol.30, pp.339-342, 2016.

R. M. Wake, J. N. Jarvis, T. S. Harrison, and N. P. Govender, Brief report: point of care cryptococcal antigen screening: pipetting finger-prick blood improves performance of immunomycologics lateral flow assay, J Acquir Immune Defic Syndr, vol.78, pp.574-578, 2018.

J. Hakim, V. Musiime, and A. J. Szubert, Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa, N Engl J Med, vol.377, pp.233-245, 2017.

M. W. &amp;-tenforde, A. E. Shapiro, and B. Rouse, Treatment for HIV-associated cryptococcal meningitis, Cochrane Database Syst Rev, vol.7, p.5647, 2018.

, The Cochrane review has appraised all completed clinical trials providing different antifungal treatment regimens to reflect recently acquired evidence and support the updating of WHO guidelines

M. Nelson, D. Dockrell, and S. Edwards, British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals, HIV Med, vol.12, issue.2, pp.1-140, 2011.

J. Lestner, L. Mcentee, and A. Johnson, Experimental models of short courses of liposomal amphotericin B for induction therapy for cryptococcal meningitis, Antimicrob Agents Chemother, vol.61, pp.90-107, 2017.

T. Bicanic, C. Bottomley, and A. Loyse, Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis, Antimicrob Agents Chemother, vol.59, pp.7224-7231, 2015.

J. Rhein, B. M. Morawski, and K. H. Hullsiek, Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label doseranging study, Lancet Infect Dis, vol.16, pp.809-818, 2016.

J. Rhein, K. H. Hullsiek, and L. Tugume, Adjunctive sertaline in HIV-associated cryptococcal meningitis. CROI; 4-7, 2018.

, The oral presentation outlined the findings of the ASTRO study which found that adjunctive sertraline during induction treatment for cryptococcal meningitis had no impact on mortality

S. R. Lockhart, A. W. Fothergill, and N. Iqbal, The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against cryptococcus neoformans and Cryptococcus gattii, Antimicrob Agents Chemother, vol.60, pp.2528-2531, 2016.

G. L. Nixon, L. Mcentee, and A. Johnson, Repurposing and reformulation of the antiparasitic agent flubendazole for treatment of cryptococcal meningoencephalitis, a neglected fungal disease, Antimicrob Agents Chemother, vol.62, pp.1909-1926, 2018.

M. Truong, L. G. Monahan, D. A. Carter, and I. G. Charles, Repurposing drugs to fasttrack therapeutic agents for the treatment of cryptococcosis, PeerJ, vol.6, p.4761, 2018.

J. Beardsley, N. Hoang, and F. M. Kibengo, Do intra-cerebral cytokine responses explain the harmful effects of dexamethasone in HIV-associated cryptococcal meningitis?, Clin Infect Dis, 2018.

G. J. Smilnak, L. T. Charalambous, and D. Cutshaw, Novel treatment of cryptococcal meningitis via neurapheresis therapy, J Infect Dis, vol.218, pp.1147-1154, 2018.

, The interesting proof of concept study used a process called neurapheresis to filter the circulating cerebrospinal fluid of rabbits infected with cryptococcus

M. A. Rolfes, K. H. Hullsiek, and J. Rhein, The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis, Clin Infect Dis, vol.59, pp.1607-1614, 2014.

T. H. Boyles, E. Gatley, S. Wasserman, and G. Meintjes, Brief report: flow rate of cerebrospinal fluid through a spinal needle can accurately predict intracranial pressure in cryptococcal meningitis, J Acquir Immune Defic Syndr, vol.74, pp.64-66, 2017.

K. T. Thakur, K. Mateyo, and L. Hachaambwa, Lumbar puncture refusal in subSaharan Africa: a call for further understanding and intervention, Neurology, vol.84, pp.1988-1990, 2015.

J. Rhein, K. H. Hullsiek, and E. E. Evans, Detrimental outcomes of unmasking cryptococcal meningitis with recent ART initiation, Open Forum Infectious Diseases, vol.5, p.122, 2018.

I. &amp;&amp;-eshun-wilson, M. P. Okwen, M. Richardson, and T. Bicanic, Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis, Cochrane Database Syst Rev, vol.7, p.9012, 2018.

C. C. Chang, S. Omarjee, and A. Lim, Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome, J Infect Dis, vol.208, pp.1604-1612, 2013.

J. N. Jarvis, G. Meintjes, and T. Bicanic, Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis, PLoS Pathog, vol.11, p.1004754, 2015.

H. A. Yoon, A. Nakouzi, and C. C. Chang, Association between plasma antibody responses and risk for Cryptococcus-associated immune reconstitution inflammatory syndrome, J Infect Dis, 2018.

J. N. Jarvis and T. S. Harrison, Understanding causal pathways in cryptococcal meningitis immune reconstitution inflammatory syndrome, J Infect Dis, 2018.

, Gilead Sciences announces steep discounts for Ambisome to treat cryptococcal meningitis in low-and middle-income countries, 2018.

, FDA adds four tropical diseases to priority review voucher program to encourage drug development in areas of unmet need, 2018.

S. F. Molloy, T. Chiller, and G. S. Greene, Cryptococcal meningitis: a neglected NTD?, PLoS Negl Trop Dis, vol.11, p.5575, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01570237